133 related articles for article (PubMed ID: 30855963)
1. Conformational Properties of the Chemotherapeutic Drug Analogue Epothilone A: How to Model a Flexible Protein Ligand Using Scarcely Available Experimental Data.
Dolenc J; van Gunsteren WF; Prota AE; Steinmetz MO; Missimer JH
J Chem Inf Model; 2019 May; 59(5):2218-2230. PubMed ID: 30855963
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling study on the tubulin-binding modes of epothilone derivatives: Insight into the structural basis for epothilones activity.
Jiménez VA; Alderete JB; Navarrete KR
Chem Biol Drug Des; 2017 Dec; 90(6):1247-1259. PubMed ID: 28632973
[TBL] [Abstract][Full Text] [Related]
3. Molecular recognition of epothilones by microtubules and tubulin dimers revealed by biochemical and NMR approaches.
Canales A; Nieto L; Rodríguez-Salarichs J; Sánchez-Murcia PA; Coderch C; Cortés-Cabrera A; Paterson I; Carlomagno T; Gago F; Andreu JM; Altmann KH; Jiménez-Barbero J; Díaz JF
ACS Chem Biol; 2014 Apr; 9(4):1033-43. PubMed ID: 24524625
[TBL] [Abstract][Full Text] [Related]
4. Structural insight into the mechanism of epothilone A bound to beta-tubulin and its mutants at Arg282Gln and Thr274Ile.
Shi G; Wang Y; Jin Y; Chi S; Shi Q; Ge M; Wang S; Zhang X; Xu S
J Biomol Struct Dyn; 2012; 30(5):559-73. PubMed ID: 22731768
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into epothilones antitumor activity based on the conformational preferences and tubulin binding modes of epothilones A and B obtained from molecular dynamics simulations.
Jiménez VA; Alderete JB; Navarrete KR
J Biomol Struct Dyn; 2015; 33(4):789-803. PubMed ID: 24773261
[TBL] [Abstract][Full Text] [Related]
6. The binding mode of side chain- and C3-modified epothilones to tubulin.
Erdélyi M; Navarro-Vázquez A; Pfeiffer B; Kuzniewski CN; Felser A; Widmer T; Gertsch J; Pera B; Díaz JF; Altmann KH; Carlomagno T
ChemMedChem; 2010 Jun; 5(6):911-20. PubMed ID: 20432490
[TBL] [Abstract][Full Text] [Related]
7. Quantum-chemical study on the bioactive conformation of epothilones.
Jiménez VA
J Chem Inf Model; 2010 Dec; 50(12):2176-90. PubMed ID: 21077585
[TBL] [Abstract][Full Text] [Related]
8. Comparative binding energy (COMBINE) analysis supports a proposal for the binding mode of epothilones to β-tubulin.
Coderch C; Klett J; Morreale A; Fernando Díaz J; Gago F
ChemMedChem; 2012 May; 7(5):836-43. PubMed ID: 22431398
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of epothilone D-bound, epothilone B-bound, and substrate-free forms of cytochrome P450epoK.
Nagano S; Li H; Shimizu H; Nishida C; Ogura H; Ortiz de Montellano PR; Poulos TL
J Biol Chem; 2003 Nov; 278(45):44886-93. PubMed ID: 12933799
[TBL] [Abstract][Full Text] [Related]
10. The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography.
Nettles JH; Li H; Cornett B; Krahn JM; Snyder JP; Downing KH
Science; 2004 Aug; 305(5685):866-9. PubMed ID: 15297674
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of isotopically labeled epothilones.
Ganesh T; Brodie PJ; Banerjee A; Bane S; Kingston DG
J Labelled Comp Radiopharm; 2014 Feb; 57(2):78-81. PubMed ID: 24307484
[TBL] [Abstract][Full Text] [Related]
12. Conformational preferences of natural and C3-modified epothilones in aqueous solution.
Erdélyi M; Pfeiffer B; Hauenstein K; Fohrer J; Gertsch J; Altmann KH; Carlomagno T
J Med Chem; 2008 Mar; 51(5):1469-73. PubMed ID: 18271516
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the Epothilone Binding Site on β-Tubulin by Photoaffinity Labeling: Identification of β-Tubulin Peptides TARGSQQY and TSRGSQQY as Targets of an Epothilone Photoprobe for Polymerized Tubulin.
Ranade AR; Higgins L; Markowski TW; Glaser N; Kashin D; Bai R; Hong KH; Hamel E; Höfle G; Georg GI
J Med Chem; 2016 Apr; 59(7):3499-514. PubMed ID: 26986898
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for drug resistance conferred by β-tubulin mutations: a molecular modeling study on native and mutated tubulin complexes with epothilone B.
Navarrete KR; Alderete JB; Jiménez VA
J Biomol Struct Dyn; 2015; 33(12):2530-40. PubMed ID: 26081685
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of action of microtubule-stabilizing anticancer agents.
Prota AE; Bargsten K; Zurwerra D; Field JJ; Díaz JF; Altmann KH; Steinmetz MO
Science; 2013 Feb; 339(6119):587-90. PubMed ID: 23287720
[TBL] [Abstract][Full Text] [Related]
16. The tubulin-bound conformation of discodermolide derived by NMR studies in solution supports a common pharmacophore model for epothilone and discodermolide.
Sánchez-Pedregal VM; Kubicek K; Meiler J; Lyothier I; Paterson I; Carlomagno T
Angew Chem Int Ed Engl; 2006 Nov; 45(44):7388-94. PubMed ID: 17036370
[No Abstract] [Full Text] [Related]
17. Synthesis, Biological Profiling and Determination of the Tubulin-Bound Conformation of 12-Aza-Epothilones (Azathilones).
Jantsch A; Nieto L; Gertsch J; Rodríguez-Salarichs J; Matesanz R; Jiménez-Barbero J; Díaz JF; Canales Á; Altmann KH
Molecules; 2016 Aug; 21(8):. PubMed ID: 27527129
[TBL] [Abstract][Full Text] [Related]
18. Utilization of alternate substrates by the first three modules of the epothilone synthetase assembly line.
Schneider TL; Walsh CT; O'Connor SE
J Am Chem Soc; 2002 Sep; 124(38):11272-3. PubMed ID: 12236733
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and SAR of C12-C13-oxazoline derivatives of epothilone A.
Pfeiffer B; Hauenstein K; Merz P; Gertsch J; Altmann KH
Bioorg Med Chem Lett; 2009 Jul; 19(14):3760-3. PubMed ID: 19433359
[TBL] [Abstract][Full Text] [Related]
20. Understanding the basis of drug resistance of the mutants of αβ-tubulin dimer via molecular dynamics simulations.
Natarajan K; Senapati S
PLoS One; 2012; 7(8):e42351. PubMed ID: 22879949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
